Trung Huynh
Stock Analyst at RBC Capital
(4.90)
# 261
Out of 5,124 analysts
366
Total ratings
78.7%
Success rate
22.9%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Reiterated: Hold | $25 → $28 | $29.23 | -4.21% | 44 | Nov 3, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €75.00 → €80.00 | €85.76 | -6.72% | 22 | Nov 2, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 15,250p | 14,066p | +8.42% | 21 | Nov 2, 2026 | |
| ABBV AbbVie | Rated: Buy | $280 → $330 | $293.30 | +12.51% | 20 | Oct 30, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $64 | $62.14 | +2.99% | 31 | Oct 29, 2026 | |
| LLY Eli Lilly and Company | Rated: Buy | $1,500 → $1,600 | $1,411.95 | +13.32% | 33 | Oct 29, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 130.00 | CHF 133.46 | -2.59% | 17 | Oct 27, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | CHF 400.00 | CHF 401.10 | -0.27% | 19 | Oct 27, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,975p → 1,925p | 1,905p | +1.08% | 19 | Oct 27, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $280 | $282.11 | -0.75% | 10 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $145 → $140 | $148.76 | -5.89% | 30 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $595 → $660 | $919.96 | n/a | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $25 | $16.37 | n/a | 4 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $140 | $116.10 | n/a | 10 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $326 → $317 | $465.23 | n/a | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.2 → $1 | $1.29 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $38 | $31.24 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.50 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $12 | $5.17 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.237 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €10.00 → €13.50 | €11.38 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 700.00 → CHF 580.00 | CHF 659.40 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €44.00 → €40.00 | €53.10 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €14.00 → €12.00 | €10.50 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €105.00 | €163.40 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €57.00 | €56.62 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $8.69 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €165.00 | €149.20 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $71 | $41.38 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.33 | $55.80 | n/a | 2 | Jun 25, 2020 |
Pfizer
Nov 3, 2026
Reiterated: Hold
Price Target: $25 → $28
Current: $29.23
Upside: -4.21%
Sanofi
Nov 2, 2026
Reiterated: Hold
Price Target: €75.00 → €80.00
Current: €85.76
Upside: -6.72%
AstraZeneca PLC
Nov 2, 2026
Reiterated: Buy
Price Target: 15,250p
Current: 14,066p
Upside: +8.42%
AbbVie
Oct 30, 2026
Rated: Buy
Price Target: $280 → $330
Current: $293.30
Upside: +12.51%
Bristol-Myers Squibb Company
Oct 29, 2026
Reiterated: Hold
Price Target: $64
Current: $62.14
Upside: +2.99%
Eli Lilly and Company
Oct 29, 2026
Rated: Buy
Price Target: $1,500 → $1,600
Current: $1,411.95
Upside: +13.32%
Novartis AG
Oct 27, 2026
Reiterated: Hold
Price Target: CHF 130.00
Current: CHF 133.46
Upside: -2.59%
Roche Holding AG
Oct 27, 2026
Reiterated: Buy
Price Target: CHF 400.00
Current: CHF 401.10
Upside: -0.27%
GSK plc
Oct 27, 2026
Reiterated: Hold
Price Target: 1,975p → 1,925p
Current: 1,905p
Upside: +1.08%
Johnson & Johnson
Oct 27, 2026
Reiterated: Buy
Price Target: $280
Current: $282.11
Upside: -0.75%
Oct 27, 2026
Reiterated: Hold
Price Target: $145 → $140
Current: $148.76
Upside: -5.89%
Nov 7, 2025
Reiterated: Hold
Price Target: $595 → $660
Current: $919.96
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $29 → $25
Current: $16.37
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $133 → $140
Current: $116.10
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $326 → $317
Current: $465.23
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $1.2 → $1
Current: $1.29
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $44 → $38
Current: $31.24
Upside: n/a
Apr 1, 2025
Reiterated: Buy
Price Target: $10 → $7
Current: $1.50
Upside: n/a
Mar 29, 2025
Reiterated: Buy
Price Target: $13 → $12
Current: $5.17
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4
Current: $0.237
Upside: n/a
Aug 24, 2023
Reiterated: Hold
Price Target: €10.00 → €13.50
Current: €11.38
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 659.40
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: €44.00 → €40.00
Current: €53.10
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: €14.00 → €12.00
Current: €10.50
Upside: n/a
Apr 13, 2022
Reiterated: Hold
Price Target: €105.00
Current: €163.40
Upside: n/a
Dec 13, 2021
Reiterated: Hold
Price Target: €57.00
Current: €56.62
Upside: n/a
Aug 4, 2021
Reiterated: Buy
Price Target: $28 → $30
Current: $8.69
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: €165.00
Current: €149.20
Upside: n/a
Oct 12, 2020
Reiterated: Buy
Price Target: $54 → $71
Current: $41.38
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.33
Current: $55.80
Upside: n/a